http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101215069-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101215069-B1 |
| titleOfInvention | Anticancer composition containing GN 1 |
| abstract | The present invention relates to an anticancer composition containing GKN 1 as an active ingredient, and more particularly to an anticancer composition containing an expression vector or GKN 1 protein containing an excellent GKN 1 gene as an active ingredient. . GKN 1 according to the present invention is not only excellent in the activity of inhibiting the development of cancer cells, but also has an excellent feature of inhibiting the metastasis of cancer cells during overexpression, there is an effect that can be usefully used as an anticancer composition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190018809-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190020364-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210049014-A |
| priorityDate | 2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 215.